Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Verrica Pharmaceuticals Inc (VRCA)

Verrica Pharmaceuticals Inc (VRCA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 318,150
  • Shares Outstanding, K 42,420
  • Annual Sales, $ 5,120 K
  • Annual Income, $ -67,000 K
  • 60-Month Beta 1.56
  • Price/Sales 61.84
  • Price/Cash Flow N/A
  • Price/Book 205.07
Trade VRCA with:

Options Overview Details

View History
  • Implied Volatility 77.23% ( +28.80%)
  • Historical Volatility 71.11%
  • IV Percentile 12%
  • IV Rank 24.33%
  • IV High 226.41% on 08/24/23
  • IV Low 29.25% on 06/21/24
  • Put/Call Vol Ratio 0.00
  • Today's Volume 3
  • Volume Avg (30-Day) 11
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 1,430
  • Open Int (30-Day) 1,438

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.43
  • Number of Estimates 3
  • High Estimate -0.40
  • Low Estimate -0.47
  • Prior Year -0.24
  • Growth Rate Est. (year over year) -79.17%

Price Performance

See More
Period Period Low Period High Performance
1-Month
6.88 +9.01%
on 06/25/24
9.36 -19.87%
on 06/06/24
-1.08 (-12.59%)
since 06/03/24
3-Month
6.08 +23.36%
on 04/04/24
11.41 -34.27%
on 05/14/24
+1.34 (+21.75%)
since 04/03/24
52-Week
2.86 +162.24%
on 11/14/23
11.41 -34.27%
on 05/14/24
+1.50 (+25.00%)
since 07/03/23

Most Recent Stories

More News
Why Shares of Verrica Pharmaceuticals Are Plummeting on Monday

The company's shares dropped because it will require financing to help launch its first marketed product.

VRCA : 7.50 (+0.40%)
2 Breakout Growth Stocks to Buy for the Long Haul

These two healthcare stocks have crushed the broader markets this year.

ACRV : 6.14 (+0.99%)
VRCA : 7.50 (+0.40%)
Verrica Pharmaceuticals Reports Second Quarter 2022 Financial Results

Verrica held Type A meeting with the FDA regarding the path forward for the resubmission and potential approval of the NDA for VP-102 for the treatment of...

VRCA : 7.50 (+0.40%)
VRCA SHAREHOLDER ALERT: Jakubowitz Law Reminds Verrica Shareholders of a Lead Plaintiff Deadline of August 5, 2022

/PRNewswire/ -- Jakubowitz Law announces that a securities fraud class action lawsuit has commenced on behalf of shareholders of Verrica Pharmaceuticals, Inc....

VRCA : 7.50 (+0.40%)
FINAL DEADLINE ALERT: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

/PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Verrica Pharmaceuticals...

VRCA : 7.50 (+0.40%)
Deadline Alert - Bronstein, Gewirtz & Grossman, LLC Reminds Verrica Pharmaceuticals Inc. (VRCA) Investors of Class Action and Last Few Hours to Actively Participate

Attorney Advertising-Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (NASDAQ:...

VRCA : 7.50 (+0.40%)
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Verrica Pharmaceuticals Inc. (VRCA)

The Law Offices of Frank R. Cruz reminds investors of the upcoming August 5, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who acquired Verrica Pharmaceuticals...

VRCA : 7.50 (+0.40%)
INVESTIGATION REMINDER: The Schall Law Firm Encourages Investors in Verrica Pharmaceuticals Inc. with Losses of $100,000 to Contact the Firm

The Schall Law Firm , a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Verrica Pharmaceuticals Inc. (“Verrica” or “the Company”)...

VRCA : 7.50 (+0.40%)
VRCA LAWSUIT ALERT: Levi & Korsinsky Notifies Verrica Pharmaceuticals, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline

/PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Verrica Pharmaceuticals, Inc. ("Verrica" or the "Company") (NASDAQ: VRCA) of a class action...

VRCA : 7.50 (+0.40%)
VERRICA DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Verrica Pharmaceuticals, Inc. and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, reminds investors that a class action lawsuit has been filed against Verrica Pharmaceuticals, Inc. (“Verrica” or the...

VRCA : 7.50 (+0.40%)

Business Summary

Verrica Pharmaceuticals, Inc. operates as a clinical-stage medical dermatology company. It develops and manufactures pharmaceutical products for the treatment of skin diseases such as molluscum contagiosum and dermatology. Verrica Pharmaceuticals, Inc. is based in PA, United States.

See More

Key Turning Points

3rd Resistance Point 8.05
2nd Resistance Point 7.86
1st Resistance Point 7.68
Last Price 7.50
1st Support Level 7.31
2nd Support Level 7.12
3rd Support Level 6.94

See More

52-Week High 11.41
Fibonacci 61.8% 8.14
Last Price 7.50
Fibonacci 50% 7.13
Fibonacci 38.2% 6.13
52-Week Low 2.86

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar